Cardiovascular Systems Inc 4

Accession 0000914190-13-000638

CIK 0001180145operating

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 4:22 PM ET

Size

26.0 KB

Accession

0000914190-13-000638

Form 4

Period: 2013-09-10

Director

Transactions

Exercise of In-Money
Common Stock
2013-09-10$9.28/sh+107,833$1,000,690→ 107,833 total(indirect: Easton Hunt Capital Partners, L.P.)
Sale
Common Stock
2013-09-10$20.73/sh−48,273$1,000,699→ 59,560 total(indirect: Easton Hunt Capital Partners, L.P.)
Exercise of In-Money
Warrant (Right to Buy)
2013-09-10−107,833→ 0 total(indirect: Easton Hunt Capital Partners, L.P.)
Exercise: $9.28From: 2008-09-12Exp: 2013-09-12→ Common Stock (107,833 underlying)

Holdings

Common Stock
(indirect: Easton Capital Partners, LP)
421,023
Stock Option (right to buy)
Exercise: $11.38Exp: 2017-11-12→ Common Stock (15,088 underlying)
15,088
Stock Option (right to buy)
Exercise: $8.83Exp: 2016-08-14→ Common Stock (38,820 underlying)
38,820
Restricted Stock Units
→ Common Stock (11,628 underlying)
11,628
Restricted Stock Units
→ Common Stock (21,739 underlying)
21,739
Warrant (Right to Buy)
(indirect: Easton Capital Partners, LP)
Exercise: $8.83From: 2009-02-25Exp: 2014-02-24→ Common Stock (151,617 underlying)
151,617
Restricted Stock Units
→ Common Stock (5,714 underlying)
5,714
Restricted Stock Units
→ Common Stock (10,917 underlying)
10,917
Warrant (Right to Buy)
(indirect: Easton Hunt Capital Partners, L.P.)
Exercise: $8.83From: 2009-02-25Exp: 2014-02-24→ Common Stock (151,617 underlying)
151,617
Common Stock
8,000
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-10-08→ Common Stock (4,321 underlying)
4,321
Restricted Stock Units
→ Common Stock (7,192 underlying)
7,192
Restricted Stock Units
→ Common Stock (4,580 underlying)
4,580

Footnotes (6)

[F1]Mr. Friedman disclaims beneficial ownership of shares held by Easton Capital Partners, LP except to the extent of his pecuniary interest therein.
[F2]Mr. Friedman disclaims beneficial ownership of shares held by Easton Hunt Capital Partners, L.P. except to the extent of his pecuniary interest therein.
[F3]On September 10, 2013, the reporting person exercised a warrant to purchase 107,833 shares of Cardiovascular Systems, Inc. ("CSI") common stock for $9.28 a share. The reporting person paid the exercise price on a cashless basis, resulting in CSI's withholding of 48,273 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 59,560 shares.
[F4]Fully exercisable.
[F5]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of the Company's Common Stock beginning six months following the termination of each director's board membership.
[F6]Mr. Friedman disclaims beneficial ownership of warrants held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP except to the extent of his pecuniary interest therein.

Documents

1 file

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating

IncorporatedDE